주식/증권 📉 부정적 Cytosorbents targets operating cash flow breakeven in 2H 2026 while planning DrugSorb-ATR de novo submission in late 2026/early 2027 Seeking Alpha - Market News 05/13/2026 11:31:50 PM 40회 원문 기사 보기